Comparison of Insulin glargine U-300 vs Insulin degludec using FreeStyle Libre Pro:randomised crossover study

Comparison of Insulin glargine U-300 vs Insulin degludec using FreeStyle Libre Pro:randomised crossover study - Comparison of Insulin glargine U-300 vs Insulin degludec using FreeStyle Libre Pro:randomised crossover study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026780

Enrollment

Registered

2017-04-01

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Type 2 diabetes patients using degludec were assigned to glargin U-300 group and degludec group by the envelope method, each patient was fitted with Libre Pro and targeted to the pre-breakfast blood g

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 40 patients with type 2 diabetes using insulin degludec (excluding patients with additional insulin)

Exclusion criteria

Exclusion criteria: Severe renal dysfunction Judged to be unsuitable for participation for medical reasons

Design outcomes

Primary

Measure	Time frame
<70mg/dL hypoglycemia	—

Secondary

Measure	Time frame
CV-value mean glucose level,SD M-value,MODD, <54mg/dL hypogliycemia	—

Countries

Japan

Contacts

Public ContactMizuho Yamabe

Murakami Memorial Hospital Department of Diabetes Internal medicine

mk-hp2@able.ocn.ne.jp0848-22-3131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026